It’s critical to understand what a digitally savvy HCP is in 2025 and what’s impeding pharma's communications with this ...

AbbVie has agreed to pay $65 million on an ... for treatment-resistant depression and MDD with suicidal ideation or behaviour. Also in Gilgamesh’s pipeline are GM-2505, a short-acting serotonin ...

AbbVie has filed with the FDA to extend the ... limited to people with depression as well as suicidal ideation and behaviour. Spravato was held up as a potential blockbuster at one point, but ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Home Depot, Inc. (HD), Booking ...

Warren Buffett has long been a proponent of value investing, which has helped him amass a personal fortune of around $150 ...

AbbVie reported better-than-expected fourth-quarter earnings. Strong demand for the company's Skyrizi and Rinvoq autoimmune therapeutics has helped offset the decline in Humira sales since losing ...

AbbVie CEO Robert Michael will soon add the role of board chairman to his résumé. Michael, who became CEO of the North Chicago-based pharmaceutical giant last summer, will assume duties as ...

Given enhanced features, the rapid shift to online shopping, and rapid digital transformation, the grocery tech industry ...

AbbVie (NYSE: ABBV) closed out a pivotal 2024 with an excellent fourth-quarter earnings report. For the period ended Dec. 31, the biopharmaceuticals giant delivered 6% sales growth and $2.12 in ...

UCB’s Bimzelx is firmly on physicians’ radars, with Spherix Global Insights finding that awareness of the drug was tracking ahead of AbbVie’s Rinvoq and Skyrizi three months into its ...

The global Cystic Fibrosis Market is valued at $10.4 billion in 2023 and is projected to reach $55.4 billion by 2032, ...

LONDON, Feb 15 (Reuters) - The Royal Society scientific academy said it would hold a meeting to discuss principles around the public pronouncements and behaviours of its fellows after thousands of ...